GJE Client News: NEC OncoImmunity AS announces AI-Developed “Universal Blueprints” for Vaccines against COVID-19

On 22 April, NEC OncoImmunity AS revealed the results of its robust artificial intelligence (AI)-driven prediction platform in the designing of optimised vaccine compositions suitable for combating the outbreak of COVID-19 around the globe.

In a cutting-edge approach now revealed in their published paper, the bioinformatics company profiled thousands of full SARS-CoV-2 sequences and applied their sophisticated AI platform to identify hotspots of vaccine targets across a variety of the viral proteins, whilst avoiding any sequences that may have detrimental similarity to human proteins. As a crucial further step in their digital analysis, the algorithms predicted the efficacy of such targets across the top 100 HLA types (or immune diversities) around the world.

As a result, these AI-generated hits represent a universal blueprint of COVID-19 vaccines, optimised for their ability to safely stimulate broad and effective immune responses against the coronavirus amongst a diverse spectrum of individuals.

As the world rushes to combat COVID-19 through trial and error, NEC OncoImmunity AS’s tech-driven approach may have defined a solution.

Gill Jennings & Every LLP worked closely with the lead scientists to help protect the core concepts of the invention. The GJE team – led by partners Matt Hoyles and John Jappy, as well as Mark Aldred and Olly Beswetherick – were inspired by the exciting nature of the project, and feel a new found sense of optimism regarding an end to this global crisis.

To read the full NEC press release, please visit their website here.

Get in touch

If you are an ambitious business and you expect an IP service provider that can understand and help you achieve your commercial objectives, then we want to work with you. Complete the enquiry form below and one of our specialists will be in touch within one working day. Alternatively you can call us on +44 (0)20 7655 8500. We look forward to hearing from you.